120 related articles for article (PubMed ID: 15717696)
1. Fludarabine-based conditioning used in successful bone marrow transplantation from an unrelated donor in a heavily transfused patient with severe aplastic anemia.
Abe Y; Matsushima T; Tachikawa Y; Nagasawa E; Nishimura J; Nawata H; Muta K
Int J Hematol; 2005 Jan; 81(1):81-2. PubMed ID: 15717696
[No Abstract] [Full Text] [Related]
2. Alemtuzumab, fludarabine and melphalan as a conditioning therapy in severe aplastic anemia and hypoplastic myelodysplastic syndrome--single center experience.
Rzepecki P; Sarosiek T; Szczylik C
Jpn J Clin Oncol; 2006 Jan; 36(1):46-9. PubMed ID: 16423840
[TBL] [Abstract][Full Text] [Related]
3. Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia.
Kang HJ; Shin HY; Choi HS; Ahn HS
Bone Marrow Transplant; 2004 Dec; 34(11):939-43. PubMed ID: 15489866
[TBL] [Abstract][Full Text] [Related]
4. Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: A phase II prospective multicenter study.
Kang HJ; Shin HY; Park JE; Chung NG; Cho B; Kim HK; Kim SY; Lee YH; Lim YT; Yoo KH; Sung KW; Koo HH; Im HJ; Seo JJ; Park SK; Ahn HS;
Biol Blood Marrow Transplant; 2010 Nov; 16(11):1582-8. PubMed ID: 20685256
[TBL] [Abstract][Full Text] [Related]
5. Alternative donor marrow transplantation in children with aplastic anemia using low-dose irradiation and fludarabine-based conditioning.
Yabe M; Shimizu T; Morimoto T; Koike T; Takakura H; Suganuma E; Sugiyama N; Kato S; Yabe H
Bone Marrow Transplant; 2011 Aug; 46(8):1148-50. PubMed ID: 20956956
[No Abstract] [Full Text] [Related]
6. A fludarabine-based conditioning regimen for severe aplastic anemia.
Chan KW; Li CK; Worth LL; Chik KW; Jeha S; Shing MK; Yuen PM
Bone Marrow Transplant; 2001 Jan; 27(2):125-8. PubMed ID: 11281379
[TBL] [Abstract][Full Text] [Related]
7. Graft failure and severe autoimmune haemolysis following fludarabine-based reduced-intensity matched unrelated donor bone marrow transplantation for severe aplastic anaemia: salvage by second transplant with conventional dose conditioning.
Cutting R; Ezaydi Y; Edbrooke D; El-Ghariani K; Stamps R; Snowden JA
Bone Marrow Transplant; 2006 Aug; 38(4):317-8. PubMed ID: 16819439
[No Abstract] [Full Text] [Related]
8. Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia.
Lee JH; Choi SJ; Lee JH; Lee YS; Seol M; Ryu SG; Lee JS; Kim WK; Lee KH
Bone Marrow Transplant; 2005 Apr; 35(8):755-61. PubMed ID: 15735661
[TBL] [Abstract][Full Text] [Related]
9. Non-radiotherapy conditioning with stem cell transplantation from alternative donors in children with refractory severe aplastic anemia.
Urban C; Benesch M; Sykora KW; Schwinger W; Lackner H
Bone Marrow Transplant; 2005 Mar; 35(6):591-4. PubMed ID: 15665850
[TBL] [Abstract][Full Text] [Related]
10. Improved Outcome of a Reduced Toxicity-Fludarabine, Cyclophosphamide, plus Antithymocyte Globulin Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia: Comparison of 2 Multicenter Prospective Studies.
Kang HJ; Hong KT; Lee JW; Kim H; Park KD; Shin HY; Lee SH; Yoo KH; Sung KW; Koo HH; Lee JW; Chung NG; Cho B; Kim HK; Koh KN; Im HJ; Seo JJ; Jung HJ; Park JE; Lee YH; Lim YT; Lim YJ; Kim SY; Yoo ES; Ryu KH; Lee JH; Park JA; Park SK; Ahn HS;
Biol Blood Marrow Transplant; 2016 Aug; 22(8):1455-1459. PubMed ID: 27090956
[TBL] [Abstract][Full Text] [Related]
11. Striking the right balance: optimizing conditioning regimens for unrelated donor bone marrow transplant for severe aplastic anemia.
Ramos CA
Biol Blood Marrow Transplant; 2012 Jul; 18(7):975-6. PubMed ID: 22609845
[No Abstract] [Full Text] [Related]
12. Fludarabine-based reduced intensity regimen for matched related donor hematopoietic stem cell transplantation in acquired severe aplastic anemia.
Ghanem KM; Kharfan-Dabaja MA; El-Solh H; Harris N; Kreidieh N; Nehme R; Muwakkit SA; Saab R; Bazarbachi A; Abboud MR
Curr Res Transl Med; 2017 Sep; 65(3):115-119. PubMed ID: 28988743
[TBL] [Abstract][Full Text] [Related]
13. Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels.
Tolar J; Deeg HJ; Arai S; Horwitz M; Antin JH; McCarty JM; Adams RH; Ewell M; Leifer ES; Gersten ID; Carter SL; Horowitz MM; Nakamura R; Pulsipher MA; Difronzo NL; Confer DL; Eapen M; Anderlini P
Biol Blood Marrow Transplant; 2012 Jul; 18(7):1007-11. PubMed ID: 22546497
[TBL] [Abstract][Full Text] [Related]
14. Haploidentical haematopoietic stem cell transplantation using CD3 or CD3/CD19 depletion and conditioning with fludarabine, cyclophosphamide and antithymocyte globulin for acquired severe aplastic anaemia.
Koh KN; Im HJ; Kim BE; Choi ES; Jang S; Kwon SW; Park CJ; Seo JJ
Br J Haematol; 2012 Apr; 157(1):139-42. PubMed ID: 22055111
[No Abstract] [Full Text] [Related]
15. Successful non-myeloablative stem cell transplantation for a heavily transfused woman with severe aplastic anemia complicated by heart failure.
Nishio M; Nakao S; Endo T; Fujimoto K; Takashima H; Sakai T; Bacigalupo A; Koike T; Sawada K
Bone Marrow Transplant; 2001 Oct; 28(8):783-5. PubMed ID: 11781631
[TBL] [Abstract][Full Text] [Related]
16. Less could be better: the case for reducing the dose of cyclophosphamide for children undergoing allogeneic stem cell transplant for severe aplastic anemia.
Hussein AA; Frangoul H
Pediatr Transplant; 2013 Jun; 17(4):326-7. PubMed ID: 23581860
[No Abstract] [Full Text] [Related]
17. Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning.
Gupta V; Ball SE; Sage D; Ortin M; Freires M; Gordon-Smith EC; Marsh JC
Bone Marrow Transplant; 2005 Mar; 35(5):467-71. PubMed ID: 15665848
[TBL] [Abstract][Full Text] [Related]
18. Marked improvement of cardiac function early after non-myeloablative BMT in a heavily transfused patient with severe aplastic anemia and heart failure.
Kunisaki Y; Takase K; Miyamoto T; Fukata M; Nonami A; Kamezaki K; Kaji Y; Gondo H; Harada M; Nagafuji K
Bone Marrow Transplant; 2007 Sep; 40(6):593-5. PubMed ID: 17618320
[No Abstract] [Full Text] [Related]
19. Fludarabine-based conditioning chemotherapy for allogeneic hematopoietic stem cell transplantation in acquired severe aplastic anemia.
Al-Zahrani H; Nassar A; Al-Mohareb F; Al-Sharif F; Mohamed S; Al-Anazi K; Patel M; Rasheed W; Saleh AJ; Bakr M; Ahmed S; Ibrahim K; Hussain F; Elkum N; Elhassan T; Nurgat Z; Chaudhri N; Aljurf M
Biol Blood Marrow Transplant; 2011 May; 17(5):717-22. PubMed ID: 20736079
[TBL] [Abstract][Full Text] [Related]
20. Reduced dose cyclophosphamide, fludarabine and antithymocyte globulin for sibling and unrelated transplant of children with severe and very severe aplastic anemia.
Chung NG; Lee JW; Jang PS; Jeong DC; Cho B; Kim HK
Pediatr Transplant; 2013 Jun; 17(4):387-93. PubMed ID: 23551397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
